Filter
1594
Text search:
Américas
Featured
173
324
Language
Document type
562
435
239
100
94
51
31
29
26
10
5
5
3
2
1
Countries
244
135
44
26
25
22
18
14
13
12
12
10
9
9
8
8
8
7
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
329
179
135
112
77
26
18
1
Toolboxes
186
178
147
116
81
80
63
47
43
43
41
39
38
36
33
27
25
22
18
17
17
14
14
7
4
1
Ciudad de Panamá, Panamá 2 y 3 de marzo, 2010
Informe
Ciudad de México, México - mayo 23 y 24, 2014
La Ceiba, Honduras – 18 y 19 de febrero de 2013
COVID-19 - PAHO/WHO Response Situation Updates
recommended
Please download the latest report directly from here: https://www.paho.org/en/tag/covid-19-situation-reports
This publication summarizes the facilitators and barriers that will be encountered in the deinstitutionalization process and identifies useful and proven interventions in Latin American and Caribbean countries. Four areas of work are identified with the respective guidelines or suggestions for actio
...
L’objectif de cette note conceptuelle et du cadre dont elle donne les grandes lignes est l’élimination d’un groupe de MT et de leurs effets pénalisants sur la santé (maladies énumérées au tableau 1 ci-dessous) qui, pris globalement, génèrent une charge tangible pour les personnes touch
...
96 million American adults - more than 1 - 3 - have prediabetes
La Ceiba – Honduras, 20 - 22 de febrero, 2013
Trabajemos por prisiones y países libres de tuberculosis
The purpose of this guide is to provide basic information for Federal disaster responders and other service providers who may be deployed or otherwise assigned to provide or coordinate services in American Indian/Alaska Native (AI/AN) communities.
This guide is intended to serve as a general briefi
...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2
